Trial Profile
To characterize self-reported adherence, virologic suppression and drug (Atazanavir) resistance in HIV infected adolescents failing second line of treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Oct 2016
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 23 Oct 2016 New trial record